Average Co-Inventor Count = 4.12
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pharmacia & Upjohn Company (17 from 523 patents)
2. Pfizer Corporation (14 from 4,455 patents)
3. Aclaris Therapeutics, Inc. (8 from 20 patents)
4. Confluence Life Sciences, Inc. (3 from 12 patents)
5. The Upjohn Co. (2 from 2,170 patents)
6. Other (1 from 832,843 patents)
7. Adaris Therapeutics, Inc. (1 from 1 patent)
8. Pfizer Products Inc. (47 patents)
46 patents:
1. 12297203 - Pyrrolopyrimidine ITK inhibitors
2. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
3. 11820775 - Pyrrolopyrimidine ITK inhibitors
4. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
5. 11420966 - Substituted pyrrolopyridines as JAK inhibitors
6. 11021482 - Pyrrolopyrimidine ITK inhibitors
7. 10981906 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
8. 10800775 - Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
9. 10316038 - Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
10. 10150783 - Heterocyclic ITK inhibitors for treating inflammation and cancer
11. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer
12. 9499551 - Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases
13. 9145393 - Arylpyridinone ITK inhibitors for treating inflammation and cancer
14. 8633206 - Pyrrolo[2,3-D]pyrimidine compounds
15. 8372854 - Pyrrolo[2,3-D]pyrimidine compounds